Are all quantitative postmarketing signal detection methods equal? Performance characteristics of logistic regression and Multi-item Gamma Poisson Shrinker

被引:18
作者
Berlin, Conny [1 ]
Blanch, Carles [1 ]
Lewis, David J. [1 ]
Maladorno, Dionigi D. [1 ]
Michel, Christiane [1 ]
Petrin, Michael [1 ]
Sarp, Severine [1 ]
Close, Philippe [1 ]
机构
[1] Novartis Pharma AG, Drug Safety & Epidemiol, CH-4002 Basel, Switzerland
关键词
signal detection; disproportionality; performance characteristics; PROPORTIONAL REPORTING RATIOS; PHARMACOVIGILANCE; DISPROPORTIONALITY; SURVEILLANCE; DATABASE; EVENTS;
D O I
10.1002/pds.2247
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose The detection of safety signals with medicines is an essential activity to protect public health. Despite widespread acceptance, it is unclear whether recently applied statistical algorithms provide enhanced performance characteristics when compared with traditional systems. Novartis has adopted a novel system for automated signal detection on the basis of disproportionality methods within a safety data mining application (Empirica (TM) Signal System [ESS]). ESS uses two algorithms for routine analyses: empirical Bayes Multi-item Gamma Poisson Shrinker and logistic regression (LR). Methods A model was developed comprising 14 medicines, categorized as "new" or "established." A standard was prepared on the basis of safety findings selected from traditional sources. ESS results were compared with the standard to calculate the positive predictive value (PPV), specificity, and sensitivity. PPVs of the lower one-sided 5% and 0.05% confidence limits of the Bayes geometric mean (EB05) and of the LR odds ratio (LR0005) almost coincided for all the drug-event combinations studied. Results There was no obvious difference comparing the PPV of the leading Medical Dictionary for Regulatory Activities (MedDRA) terms to the PPV for all terms. The PPV of narrow MedDRA query searches was higher than that for broad searches. The widely used threshold value of EB05 = 2.0 or LR0005 = 2.0 together with more than three spontaneous reports of the drug-event combination produced balanced results for PPV, sensitivity, and specificity. Conclusions Consequently, performance characteristics were best for leading terms with narrow MedDRA query searches irrespective of applying Multi-item Gamma Poisson Shrinker or LR at a threshold value of 2.0. This research formed the basis for the configuration of ESS for signal detection at Novartis. Copyright (C) 2011 John Wiley & Sons, Ltd.
引用
收藏
页码:622 / 630
页数:9
相关论文
共 17 条
[1]   Comparative performance of two quantitative safety signalling methods - Implications for use in a pharmacovigilance department [J].
Almenoff, June S. ;
LaCroix, Karol K. ;
Yuen, Nancy A. ;
Fram, David ;
DuMouchel, William .
DRUG SAFETY, 2006, 29 (10) :875-887
[2]  
[Anonymous], 2008, MEDDRA TERM SELECTIO
[3]   A data mining approach for signal detection and analysis [J].
Bate, A ;
Lindquist, M ;
Edwards, IR ;
Orre, R .
DRUG SAFETY, 2002, 25 (06) :393-397
[4]  
Czarnecki A, 2008, DRUG INF J, V42, P205, DOI 10.1177/009286150804200301
[5]   Association of asthma therapy and Churg-Strauss syndrome: An analysis of postmarketing surveillance data [J].
DuMouchel, W ;
Smith, ET ;
Beasley, R ;
Nelson, H ;
Yang, XH ;
Fram, D ;
Almenoff, JS .
CLINICAL THERAPEUTICS, 2004, 26 (07) :1092-1104
[6]   Antipsychotics, Glycemic Disorders, and Life-Threatening Diabetic Events: A Bayesian Data-Mining Analysis of the FDA Adverse Event Reporting System (1968-2004) [J].
Dumouchel, William ;
Fram, David ;
Yang, Xionghu ;
Mahmoud, Ramy A. ;
Grogg, Amy L. ;
Engelhart, Luella ;
Ramaswamy, Krishnan .
ANNALS OF CLINICAL PSYCHIATRY, 2008, 20 (01) :21-31
[7]   Use of measures of disproportionality in pharmacovigilance - Three Dutch examples [J].
Egberts, ACG ;
Meyboom, RHB ;
van Puijenbroek, EP .
DRUG SAFETY, 2002, 25 (06) :453-458
[8]  
EMEA. Eudravigilance Expert Working Group (EV-EWG), 2008, GUID US STAT SIGN DE
[9]   Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports [J].
Evans, SJW ;
Waller, PC ;
Davis, S .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2001, 10 (06) :483-486
[10]   Data mining in pharmacovigilance - The need for a balanced perspective [J].
Hauben, M ;
Patadia, V ;
Gerrits, C ;
Walsh, L ;
Reich, L .
DRUG SAFETY, 2005, 28 (10) :835-842